Answers are grounded in this paper and cite their sources.
Herein, we present a highly efficient dual-functionalized acid–base nanocatalyst, denoted as Fe3O4@GLYMO-HEPES, featuring sulfuric acid and tertiary amines as its dual functional components. This catalyst is synthesized through the immobilization of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) as the source of these functionalities onto magnetite (Fe3O4) using 3-glycidoxypropyltriethoxysilane (GLYMO) as a linker. Characterization studies confirm the integrity of the Fe3O4 core, with the GLYMO-HEPES coating exhibiting no phase changes. Furthermore, Fe3O4@GLYMO-HEPES nanoparticles demonstrate a uniform size distribution without aggregation. Notably, the catalyst exhibits remarkable stability up to 200 °C and possesses a saturation magnetization value of 31.5 emu/g, facilitating easy recovery via magnetic separation. These findings underscore the potential of Fe3O4@GLYMO-HEPES as a versatile and recyclable nanocatalyst for various applications. Its catalytic ability was evaluated in the synthesis of various pyrano[2,3-c]pyrazoles and 2-amino-3-cyano-4H-chromenes through a tandem Knorr–Knoevenagel–Michael–Thorpe–Ziegler-type heterocyclization mechanism, using different aldehydes. A wide range of fused heterocycles was synthesized having good to excellent yields. The process is cost-effective, safe, sustainable, and scalable, and the catalyst can be reused up to five times. The prepared catalyst was found to be highly stable and heterogeneous and showed good recyclability.
No takes yet. Share an insight, caveat, or question.
Borzooei et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: